Skip to main content
OpenTrials
Completed

NCT Number: NCT00564252

Topical Finasteride in the Treatment of Idiopathic Hirsutism

the purpose of this study is to evaluate the efficacy of topical Finasteride in the treatment of idiopathic hirsutism

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Idiopathic hirsutism which is defined as normal levels of androgens and normal ovulation
  • Normal serum prolactin

Exclusion criteria

  • Pregnancy
  • Simultaneous use of other drugs for the treatment of hirsutism

Treatment and study plan

topical finasteride

Drug

0.2%topical(cream)finasteride twice a day for six months

Primary outcomes

  1. the efficacy of topical finasteride was determined by comparison of Ferriman-Gallwey score before and after medication

    Time frame: 6 months

Secondary outcomes

  1. the efficacy of topical finasteride was determined by comparison of mean hair thickness before and after medication

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Iran University of Medical Sciences

Other

Collaborators

  • Firuzgar hospital affiliated to Iran University of Medical Sciences

Registry information

Official study title

The Efficacy of Topical Finasteride in the Treatment of Idiopathic Hirsutism

Important dates

Study start
2006
Study completion
2006
First posted
Nov 27, 2007
Registry last updated
Nov 27, 2007

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.